scholarly journals Cardiac tamponade and successful pericardiocentesis in an extremely low birth weight neonate with percutaneously inserted central venous line: a case report

Cases Journal ◽  
2010 ◽  
Vol 3 (1) ◽  
pp. 15 ◽  
Author(s):  
Alfredo Pizzuti ◽  
Emilia Parodi ◽  
Paola Abbondi ◽  
Mario Frigerio
2013 ◽  
Vol 2 (1-2) ◽  
Author(s):  
Emma Gates ◽  
Ben Shaw ◽  
George Kokai

AbstractPericardial effusion and cardiac tamponade are known to be rare but potentially fatal complications of umbilical venous catheterisation, even when the line tip is appropriately placed and is proximal to the right atrium.We report a fatal case of cardiac tamponade due to the presence of pericardial total parenteral nutrition associated with bilateral pleural effusions in an extremely low birth weight neonate with an umbilical venous catheter.It is important to promptly identify and treat this rare but devastating complication of what is often considered “routine” care. Timely pericardiocentesis should be considered in a preterm baby who deteriorates suddenly and has a central venous catheter


PEDIATRICS ◽  
1992 ◽  
Vol 89 (4) ◽  
pp. 689-690
Author(s):  
ORNA FLIDEL ◽  
YIGAL BARAK ◽  
BEATRIZ LIFSCHITZ-MERCER ◽  
AZRIEL FRUMKIN ◽  
BENJAMIN M. MOGILNER

To the Editor.— Graft vs host disease (GVHD) in extremely low birth weight neonates following multiple blood transfusions is probably more frequent than is generally thought.1 Recently, such a case was described by Funkhouser et al.2 We wish to report our experience with an extremely low birth weight neonate with GVHD, presumably induced by blood transfusions. Immunotherapy with rat antilymphocyte monoclonal antibody(Campath 1G) failed to induce any clinical change. The patient was a boy,


2018 ◽  
Vol 15 (01) ◽  
pp. 057-060
Author(s):  
Katherine M. Malloy ◽  
Kristen R. Nichols ◽  
Anna E. Thomas

AbstractWe report on the diagnosis and treatment of a Candida nivariensis urinary tract infection in an extremely low-birth-weight neonate. The isolate was identified by MALDI-TOF technology and is the first known report of C. nivariensis in the neonatal or pediatric population. Treatment was initiated with amphotericin B deoxycholate and later completed with intravenous fluconazole following susceptibility results.


Sign in / Sign up

Export Citation Format

Share Document